Evaluating community pharmacists' perceptions of future generic substitution policy implementation: A national survey from Malaysia

Chee Ping Chong, Mohamed Azmi Hassali, Mohd Baidi Bahari and Asrul Shafie ()

Health Policy, 2010, vol. 94, issue 1, 68-75

Abstract: Objectives This study aims to provide baseline data to support the implementation of generic substitution policy in Malaysia by evaluating the community pharmacists' perceptions and opinions on generic substitution and current substitution practices.Methods A cross-sectional descriptive study involving the entire population of Malaysian community pharmacies (n = 1419) was undertaken using a self-completed anonymous mail questionnaire.Results A total of 219 responses were received for a response rate of 15.4%. Majority of the respondents (93.6%) agreed that pharmacists should have generic substitution rights. Almost all pharmacists (96.8%) viewed Poison Class C (pharmacist only medicine) as most suitable class of controlled medicines for substitution. About half (51.6%) of the pharmacists preferred a policy which allowed substitution on any prescription. The pharmacists prefer to consult the physician when substituting narrow therapeutic index medicines (88.1%) and prescription only medicines (51.3%). Less than 25.0% of the pharmacists routinely keep the medication records and follow-up the patients who received substitution. Monitoring the efficacy (79.2%) and patient's satisfaction with the generic medicines (74.9%) were the main reasons for following-up the patient if substitution occurs.Conclusions Malaysian community pharmacists are generally in favour of generic substitution policy implementation.

Keywords: Community; pharmacist; Perception; Generic; substitution; Generic; medicine; Policy (search for similar items in EconPapers)
Date: 2010
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168-8510(09)00231-0
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:94:y:2010:i:1:p:68-75

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().